Revolutionizing BioTech with 3D Printing
InkSpire 3D is aiming to revolutionise biotechnology through the creation of 3D printed structures using in-house designed biocompatible inks. Our innovative approach is paving the way for translational science and driving the future of sustainable biotechnology. At InkSpire 3D, we are dedicated to providing cutting-edge biotech solutions that are not only better for researchers and practitioners but also for the environment. Our commitment to create, design and restore nature drives us to create sustainable and impactful solutions for the biotech industry.

Customised Designs For Your Desired Needs

Design Iterations

_edited_edi.png)



Innovation - Driven Research
Our research is fueled by innovation and sustainability, aiming to address the pressing challenges in the restoration world. We continuously strive to develop groundbreaking solutions that have the potential to transform the landscape of biotech research and development.
Precision Data Analysis
We harness the power of precision data analysis to propel optimum research and development forward. Our data-driven approach enables us to uncover valuable insights and trends, leading to informed decision-making and impactful outcomes.
Advanced Biotech Technologies
Embracing advanced biotech technologies, we are committed to pioneering the next generation of biotech tools and methodologies.
Our focus on technological advancement uses computer-aided design (CAD) to ensure intricate virtual 3D representation of prints. We ensure that our solutions are both precisely engineered and formulated for desired applications.
Milestones
Explore Our Journey in Biotech Innovation
YEAR 2025
Establishment of InkSpire 3D
InkSpire 3D was founded with a vision to revolutionize biotech through 3D printing technology, marking the beginning of our impactful journey.
Expansion of Research Initiatives
Our research initiatives expanded, delving into new realms of biotech exploration and contributing to the advancement of biotech research.
YEAR 2021
First publication successfully displaying sustainable and eco-friendly coral restoration via 3D printing and fabrication.
Years 2021 - 2024
Further optimised, explored and researched into the field which resulted into several succesful patents and publications.
Expo 2025
Osaka, Japan
Privileged to display our designed prints for coral restoration at the Kingdom of Saudi Arabia Pavilion at the World Expo.
Remark: Further insights and stories will be published once necessary approvals are given.

Meet the team which
powers InkSpire
Discover the brilliant minds behind InkSpire 3D. Our diverse team of engineers, chemist, material scientists (some would like to stay anonymous) are dedicated to pushing the boundaries of 3D bioprinting technology.
Prof. Tadd T. Truscott
Scientific Advisor
Prof. Truscott is the Scientific lead of InkSpire. His current research interests are in fluid dynamics, novel imaging and experimental methods. He is the Principle Investigator of The Splash lab at KAUST. By merging different areas of research, he works on problems such as three-dimensional flow-field dynamics of rising and falling objects in water, acceleration induced cavitation, the transport of water through desert plants and the collective behavior of pelotons and fish.

Khadija B. Shirazi
CEO
Khadija is our Chief Executive Officer, with a background in Chemistry and a specialisation in Nanomaterials. Her expertise includes developing novel materials, sustainable and biocompatible formulations, and applying classical synthetic methods to innovative material design. Combining scientific knowledge with strategic leadership, she drives the company’s vision, fosters innovation, and leads with a focus on growth, collaboration, and long-term impact.

Dr. Ayeesha Mujeeb
Consultant, Scientific Advisor
Dr. Mujeeb is our Scientific adviser - Materials and formulations aspect. She is a materials scientist who is an expert in regenerative medicine, specialised in drug delivery systems. Dr. Mujeeb excels in supporting researchers, academicians, young entrepreneurs, and engineers to develop innovative bench- to-bedside solutions with commercial potential and application.


